Recent trends in cost‐related medication nonadherence among stroke survivors in the United States
- 22 February 2013
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 73 (2) , 180-188
Abstract
Objective Recent economic and health policy changes may have affected the ability of chronically ill patients to afford their medications. We assessed changes in cost‐related nonadherence to medication (CRN) before and after the implementation of Medicare Part D in 2006. Methods We used data from the National Health Interview Survey, an annual, population‐based survey of community‐dwelling, noninstitutionalized US adults, to estimate CRN in 8,673 stroke survivors aged 45 years or older, representing 4.8 million survivors, for the years 1999 to 2010. The main outcome measure was CRN, defined as self‐reported inability to afford prescribed medication within the past 12 months. Results During the period 1999 to 2010, 11.4% of stroke survivors, approximately 543,000 individuals, reported CRN. From 1999 to 2010, CRN more than doubled among stroke survivors aged 45 to 64 years (from 12.7 to 26.5%; p trend = 0.01). CRN remained stable among those aged 65 years or older (from 3.8 to 7.0%; p trend = 0.21). From 1999–2005 to 2006–2010, CRN among uninsured stroke survivors aged 45 to 64 years increased from 43.1 to 57.1% (p = 0.03). Among stroke survivors aged 65 years or older with Medicare coverage, CRN was higher among Medicare Part D participants than those without the drug benefit (7.9 vs 4.8%; p = 0.02). After adjustment for sociodemographic and clinical factors, CRN was similar among Medicare Part D enrollees and nonenrollees. Interpretation From 1999 to 2010, CRN increased significantly among stroke survivors younger than 65 years, particularly among those without health insurance. There was no evidence that Medicare Part D decreased CRN among stroke survivors with Medicare. ANN NEUROL 2013;73:180–188Keywords
This publication has 44 references indexed in Scilit:
- Clopidogrel Use and Early Outcomes Among Older Patients Receiving a Drug-Eluting Coronary Artery StentCirculation: Cardiovascular Quality and Outcomes, 2012
- Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial InfarctionJAMA, 2011
- Medication AdherenceCirculation, 2009
- The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and ExpendituresAnnals of Internal Medicine, 2008
- Discontinuation of Statin Therapy and Clinical Outcome After Ischemic StrokeStroke, 2007
- Financial Barriers to Health Care and Outcomes After Acute Myocardial InfarctionJAMA, 2007
- Younger Stroke Survivors Have Reduced Access to Physician Care and MedicationsArchives of Neurology, 2007
- Changes in Financial Burdens for Health CareJAMA, 2006
- High-Dose Atorvastatin after Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2006
- Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressuresJournal of Clinical Epidemiology, 2006